ARCHIVES

NCI relaxes Core Grants Support For Clinical Trials Research

This article is from The Cancer Letter archive.

Vol. 18 No. 48 | December 11, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

New Missouri Center Seeing a Director

July 16, 1982

DeVita Frustrated By Gap Between Bypass, “Real” Budgets, Seeks Better System To Develop Priorites

April 24, 1981

Pinkel, Sharp, Hausen Win GM Awards for ‘86

June 13, 1986

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

December 22, 1994

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

November 30, 1979